Vaccine Development Forum 2010

March 30 – 31, 2010
Fred Hutchinson Cancer Research Center
Seattle, Washington

The goal of the workshop is to bring together individuals from the vaccine community together to discuss the current state of vaccine development – challenges and opportunities. The first half-day of the forum (March 30) will focus on vaccine research and the second day (March 31) will cover issues surrounding vaccine production and delivery as well as challenges with commercialization and adoption.

The forum will be held in Pelton Auditorium in the Weintraub building on the Fred Hutchinson Cancer Research Center’s South Lake Union campus. Please RSVP to wava@fhcrc.org. Registration is still open.

Sponsored by: the Washington Vaccine Alliance.
Co-sponsored by: the Washington Biotechnology and Biomedical Association (WBBA), the Life Sciences Discovery Fund and the Fred Hutchinson Cancer Research Center.

See detailed agenda below.

Program Overview

Program Director
Lawrence Corey, MD
Scientific Director, WAVA
Professor, University of Washington
Member and Co-Director, Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center

Keynote Speaker
Rino Rappuoli, PhD
Global Head of Vaccines Research
Novartis

Tuesday, March 30, 2010

Tuesday, March 31, 2010

Program Faculty and Talks

Cancer Vaccines
Nora Disis, University of Washington

Novel Adjuvants
    Steven Reed, Immune Design Corporation
    Michael Gale, University of Washington
    Juliana McElrath, Fred Hutchinson Cancer
      Research Center

New Ideas
    Michael Gale, University of Washington
    Juliana McElrath, Fred Hutchinson Cancer
      Research Center
    Pat Stayton, University of Washington

Plenary Sessions

H1N1 Flu Postmortem
    Kathy Neuzil, PATH
    Jeff Duchin, Seattle and King County Public Health
    Anna Wald, University of Washington

Technical Challenge Roundtable
Dexiang Chen, PATH
Darin Zehrung, PATH

Global Rollout Challenges Roundtable
    Vivien Tsu, PATH
    Duncan Steele, PATH
    Stephen Lim, University of Washington

Keynote Address
    Rino Rappuoli, PhD
    Global Head of Vaccines Research
    Novartis

Agenda

Tuesday, March 30, 2010
1:45 PM – 1:50 PM	Welcome and Introductions Lawrence Corey, MD, WAVA Scientific Director
1:50 PM – 2:00 PM	WAVA Mission & Conference Outline Harlan Patterson, WAVA Executive Director
2:00 PM – 2:40 PM	Cancer Vaccine Nora Disis, MD, University of Washington
2:40 PM – 2:50 PM	Q & A
2:50 PM – 3:35 PM	Novel Adjuvants (Discussion Panel) Steven Reed, PhD, Immune Design Corporation Michael Gale, PhD, University of Washington Juliana McElrath, MD, PhD, Fred Hutchinson Cancer Research Center
3:35 PM – 3:50 PM	Q & A
3:50 PM – 4:05 PM	Break
4:05 PM – 5:05 PM	Session for New Ideas Juliana McElrath, MD, PhD, Fred Hutchinson Cancer Research Center Michael Gale, PhD, University of Washington Pat Stayton, PhD, University of Washington
5:05 PM – 5:20 PM	Closing Remarks
5:30 PM – 6:30 PM	Reception Double Helix Cafe

Wednesday, March 31, 2010
1:00 PM – 1:05PM	Welcome and Introductions Lawrence Corey, MD, WAVA Scientific Director
1:05 PM – 1:15 PM	WAVA Mission & Conference Outline Harlan Patterson, WAVA Executive Director
1:20 PM – 2:05 PM	Plenary Session: H1N1 Kathy Neuzil, MD, PATH Jeff Duchin, MD, Seattle and King County Public Health Anna Wald, MD, University of Washington
2:05 PM – 2:15 PM	Q & A
2:15 PM – 3:00 PM	Discussion Panel – Technical Challenges: Vaccine Thermostability; Adjuvants; Delivery Technologies Dexiang Chen, PhD, PATH Darin Zehrung, PATH
3:00 PM – 3:10 PM	Q & A
3:10 PM – 3:55 PM	Discussion Panel – Partnership Challenges: Regulatory Challenges; Industry Partnerships; Healthcare System Adoption; Global Rollout Challenges Vivien Tsu, PhD, MPH, PATH Duncan Steele,PhD, PATH Stephen Lim, PhD, University of Washington
3:55 PM – 4:05 PM	Q & A
4:05 PM – 4:20 PM	Break
4:20 PM – 5:00 PM	Keynote Address Rino Rappuoli, PhD Global Head of Vaccines Research Novartis
5:00 PM – 5:15 PM	Q & A
5:15 PM – 5:30 PM	Closing Remarks
5:30 PM – 6:30 PM	Reception Double Helix Cafe